(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ADN ADIENNE PHARMA & BIOTECH

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

ADN ADIENNE PHARMA & BIOTECH

ST13

US500000079029793

Class

5

Filing

79029793

Registration

3302942

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

48

Latest update

06/05/2026

Trademark type

Combined

Nice classes

5

Filing date

05/11/2006

Registration date

10/02/2007

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/10/2018

Last transaction

06/05/2026

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

5

Owner type

99

Owner location

IT

Examiner

MIDDLETON, BERNICE L

Law office

L60

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of The word "ADIENNE" with the words "PHARMA & BIOTECH" underneath, preceded by the letters "A D N" grouped together with the letter "D" in the foreground..

Holders and representatives

Holders

ADIENNE S.r.l.
ADIENNE SRL

Representatives

Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparationtepadinaan injectable solution for use in humans in conditioning treatment prior to stem cell transplantation

Publications

History of USPTO decisions and trademark events.

48 publications found

RNWL

INTERNATIONAL REGISTRATION RENEWED

06/04/2026

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

03/11/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/05/2022

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

10/10/2018

S71A

REGISTERED-SUBSEQUENT SEC. 71 ACCEPTED

10/10/2018

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/08/2018

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/08/2018

PRAN

POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED

04/10/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/14/2017

ES71

TEAS SECTION 71 RECEIVED

10/06/2017

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/06/2017

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

03/24/2017

71AG

REGISTERED-SEC.71 ACCEPTED

03/24/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/22/2017

ES71

TEAS SECTION 71 RECEIVED

10/07/2016

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/07/2016

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

10/02/2016

RNWL

INTERNATIONAL REGISTRATION RENEWED

05/26/2016

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

12/18/2014

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

10/16/2014

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

12/19/2012

PRAN

POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED

12/19/2012

71AG

REGISTERED-SEC.71 ACCEPTED

12/19/2012

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/19/2012

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/08/2012

ES71

TEAS SECTION 71 RECEIVED

10/03/2012

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/03/2012

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

12/14/2008

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/18/2008

FIMP

FINAL DISPOSITION PROCESSED

01/18/2008

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/09/2008

R.PR

REGISTERED-PRINCIPAL REGISTER

10/02/2007

PUBO

PUBLISHED FOR OPPOSITION

07/17/2007

NPUB

NOTICE OF PUBLICATION

06/27/2007

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

06/13/2007

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/13/2007

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/31/2007

ALIE

ASSIGNED TO LIE

05/31/2007

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/14/2007

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/14/2007

RFNT

REFUSAL PROCESSED BY IB

12/15/2006

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

11/29/2006

RFRR

REFUSAL PROCESSED BY MPU

11/29/2006

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/28/2006

CNRT

NON-FINAL ACTION WRITTEN

11/27/2006

DOCK

ASSIGNED TO EXAMINER

11/14/2006

NWAP

NEW APPLICATION ENTERED

11/14/2006

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/09/2006

Continuous trademark protection

Get notified about every new filing that threatens ADN ADIENNE PHARMA & BIOTECH or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.